Incyte Diagnostics

What Incyte Diagnostics does

Incyte Diagnostics was a clinical and anatomic pathology laboratory founded in 1957, headquartered at 13103 E. Mansfield Avenue in Spokane Valley, Washington. The company served hospitals, physician offices and clinics, and individual patients across Washington, Idaho, Oregon, Montana, and Alaska through 16 sites spanning headquarters, clinical laboratories, integrated operating locations, and patient service centers. Following its combination with Blue Mountain Pathology, Incyte offered access to 47 board-certified pathologists with expertise in 27 disciplines and subspecialties, including dermatopathology, hematopathology, molecular pathology, and surgical pathology.

The company's core technology stack combined anatomic and clinical pathology workflows: histopathology and cytology interpretation by board-certified pathologists, immunohistochemistry (IHC) panels for IgG4 disease, non-small cell lung cancer subtyping, HER2 (per ToGA guidelines), and microsatellite instability analysis for Lynch syndrome screening. Molecular diagnostics included PCR-based Candida speciation using the proprietary Incyte Swab, HPV genotyping across reflex, co-testing, and primary screening modalities, p16 IHC with high-risk HPV in situ hybridization for head and neck cancer, and strand displacement amplification (BD Viper) for Trichomonas vaginalis. Operational tooling included Incyte Connect (a provider results/ordering portal) and TeamViewer-based remote technical support.

Incyte billed primarily on a professional services fee-for-service basis to health insurance plans and patients, delivering both the professional component (pathologist interpretation) and technical component of laboratory testing, plus technical consulting to hospitals and providers. The company was CAP-accredited. Effective December 8, 2025, Labcorp completed the acquisition of Incyte's clinical pathology business, multiple same-day testing labs, and select anatomic pathology assets including the Spokane headquarters laboratory and sites in Tukwila, Richland, and Missoula, with the remaining business continuing under new ownership.

Name

Incyte Diagnostics

Legal name

Incyte Diagnostics

Website

https://incytediagnostics.com

Company type

Private

Founded year

1957

Operating status

Acquired

Headcount range

101–250 employees

Short description

Incyte Diagnostics was a Pacific Northwest clinical and anatomic pathology laboratory that provided diagnostic testing services, including molecular diagnostics and subspecialty pathology interpretation, to hospitals, healthcare providers, and patients across Washington, Idaho, Oregon, Montana, and Alaska. Its clinical pathology business and select anatomic pathology assets were acquired by Labcorp effective December 8, 2025.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology and Clinical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE)

Keywords

• Anatomic pathology services
• Clinical laboratory testing
• Molecular diagnostics testing
• Subspecialty pathology diagnostics
• Immunohistochemistry diagnostics

Headquarters

HQ city

Spokane

HQ country

United States

HQ region

North America

Offices16 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory Testing Services: Professional laboratory services billed to health insurance plans and patients. Services include pathology interpretation, molecular testing, and diagnostic services. The company provides both professional component (PC) - interpretation and reporting of specimens by pathologists - and technical component services.
2. Technical Consulting: Technical consulting services provided to healthcare providers and hospitals for laboratory operations, quality assurance, and diagnostic support.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Incyte Diagnostics is a clinical and anatomic pathology laboratory providing diagnostic testing services across the Pacific Northwest. The company offers a comprehensive suite of laboratory services including COVID testing, hospital and healthcare provider support, clinical and anatomic subspecialty pathology, a test directory, and technical consulting. Core offerings include professional pathology interpretation of Pap tests, molecular lab tests, and surgical biopsy specimens by board-certified pathologists, supported by a network of same-day testing labs and patient service centers across five states.

Product overview

Incyte Diagnostics is a clinical and anatomic pathology laboratory providing diagnostic testing services across the Pacific Northwest. The company offers a comprehensive suite of laboratory services including COVID testing, hospital and healthcare provider support, clinical and anatomic subspecialty pathology, a test directory, and technical consulting. The core offerings include professional pathology interpretation of Pap tests, molecular lab tests, and surgical biopsy specimens by board-certified pathologists. Additional services include Incyte Connect (provider portal), Remote Support (TeamViewer-based technical assistance), and patient location services. The company serves communities across Washington, Idaho, Oregon, Montana, and Alaska with multiple laboratory locations. Effective December 8, 2025, Labcorp completed the acquisition of Incyte Diagnostics' clinical pathology business and select technical assets of the anatomic pathology business.

Differentiator

Problem solved

Functional benefit

Products and services

• COVID Testing Laboratory diagnostic and antibody testing services for SARS-CoV-2 (COVID-19), offered to referring providers, hospitals, and walk-in patients at patient service centers.
• Hospital Laboratory Services Outsourced anatomic and clinical pathology and diagnostic testing services delivered to acute care hospitals requiring pathologist interpretation and laboratory support.
• Healthcare Provider Laboratory Services Professional laboratory support and diagnostic services for physician offices and clinics, including specimen evaluation and pathology reporting.
• Clinical and Anatomic Subspecialty Pathology Subspecialty pathology interpretation across multiple disciplines including dermatopathology, hematopathology, molecular pathology, and surgical pathology, supported by 47 board-certified pathologists.
• Test Directory Comprehensive catalog of available laboratory tests including Pap tests, molecular lab tests, biopsy and surgical specimens, and infectious disease testing, accessible to providers through the Incyte Diagnostics website.
• Technical Consulting Expert technical consulting services for healthcare providers covering laboratory operations, test methodology, and quality assurance.
• Professional Component of Clinical Pathology Professional pathology interpretation and reporting services including evaluation of Pap tests, molecular tests, and biopsy specimens by board-certified pathologists, billed under the professional component.
• Incyte Connect Online provider portal enabling healthcare providers to access test results, order tests, and manage patient information.

Quantifiable outcome

• Incyte Swab detection rate for Candida albicans is 18.23% compared to 13.65% for ThinPrep and 11.98% for SurePath
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• LabcorpmajorStrategic or Co-development Partner · 8 December 2025Effective December 8, 2025, Labcorp completed the acquisition of Incyte Diagnostics' clinical pathology (CP) business including multiple same-day testing labs, and select technical assets of the anatomic pathology (AP) business including the main laboratory in Spokane, Washington and labs in Tukwila and Richland, Washington; and Missoula, Montana. This represents a significant strategic transaction for both organizations.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Quest Diagnostics: Quest Diagnostics is the largest US clinical and anatomic pathology reference lab; it directly competes with Incyte for hospital, physician-office, and health-system routing across Incyte's Pacific Northwest footprint, with comparable surgical pathology, cytology, molecular, and IHC menus.
• NeoGenomics: NeoGenomics is a specialty oncology-focused clinical and anatomic pathology lab offering molecular, cytogenetic, and IHC testing for cancer diagnosis and monitoring; it competes with Incyte's molecular and oncology testing lines for hospital and oncology-center referrals.
• ProPath: ProPath is a US private pathology practice offering anatomic pathology, dermatopathology, hematopathology, and molecular diagnostics on a referral basis; it mirrors Incyte's subspecialty-driven, physician-directed model.
• ARUP Laboratories: ARUP is a major academic-affiliated reference laboratory offering extensive anatomic pathology, molecular diagnostics, and IHC services; it competes for the same complex test referrals that Incyte captures from community hospitals across the Pacific Northwest.
• PathGroup: PathGroup is one of the largest US private pathology practices, providing anatomic and clinical pathology, molecular, and subspecialty diagnostics to hospitals and physicians — directly comparable in model and service mix to Incyte's regional pathology franchise.

Broad incumbents

• Sonic Healthcare USA: Sonic Healthcare's US operations (including Aurora Diagnostics and Pathology Associates) are a direct anatomic-pathology competitor with a regional, subspecialty-driven model that closely mirrors Incyte's hospital-and-clinic referral network.
• Mayo Clinic Laboratories: Mayo Clinic Laboratories is a large academic reference lab competing for esoteric and complex anatomic pathology referrals that Incyte and other regional pathology groups also pursue; it sets clinical credibility benchmarks for tertiary testing.
• Labcorp Diagnostics: Labcorp is the second-largest US clinical reference lab and now owns Incyte's clinical pathology and select anatomic pathology assets (Dec 2025); it is the most direct large-network competitor in routine and specialty lab services across the same geography.

Regional players

• CellNetix Pathology & Laboratories: CellNetix is a Pacific Northwest–based subspecialty pathology group headquartered in the Seattle area; it is the closest regional direct competitor to Incyte across Washington, Alaska, and Oregon for hospital and outpatient anatomic pathology.

Emerging players

• Guardant Health: Guardant Health is a liquid-biopsy and molecular oncology diagnostics company whose tumor-profiling and MRD tests increasingly overlap with the molecular and IHC oncology work Incyte performs for community oncologists.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/IncyteDiagnostics
• LinkedInlinkedin.com/company/incyte-pathology
• Instagraminstagram.com/incytediagnostics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Incyte Diagnostics